Gland Pharma informs about press release

03 Dec 2024 Evaluate
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it attached announcement regarding the receipt of US FDA approval for Latanoprost Ophthalmic Solution, 0.005% (2.5 mL Fill).

The above information is a part of company’s filings submitted to BSE.

Gland Pharma Share Price

1796.85 -16.90 (-0.93%)
04-Dec-2024 13:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.85
Dr. Reddys Lab 1219.65
Cipla 1504.05
Lupin 2094.65
Zydus Lifesciences 969.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.